Dengvaxia's Safety: Should Hospitalization Be a Clinical Trial Outcome?

Authors
  • Marco Schaerf

    English

    Author

Keywords:
cost-effectiveness
Abstract

In the Philippines, doctors, parents, and legislators are all still plagued by doubts about the safety and effectiveness
of Dengvaxia. There have been ongoing reports of deaths among those who received the vaccine between 2016 and
2017, with an unofficial total of 29 deaths to far, following the mass vaccination of about 850,000 youngsters with
Dengvaxia

Downloads
Published
2025-10-23
Section
Articles